119 related articles for article (PubMed ID: 23748247)
1. Is the conformational flexibility of piperazine derivatives important to inhibit HIV-1 replication?
Teixeira C; Serradji N; Amroune S; Storck K; Rogez-Kreuz C; Clayette P; Barbault F; Maurel F
J Mol Graph Model; 2013 Jul; 44():91-103. PubMed ID: 23748247
[TBL] [Abstract][Full Text] [Related]
2. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
Teixeira C; Serradji N; Maurel F; Barbault F
Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
Sivan SK; Vangala R; Manga V
Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
[TBL] [Abstract][Full Text] [Related]
4. In silico study on indole derivatives as anti HIV-1 agents: a combined docking, molecular dynamics and 3D-QSAR study.
Balupuri A; Gadhe CG; Balasubramanian PK; Kothandan G; Cho SJ
Arch Pharm Res; 2014 Aug; 37(8):1001-15. PubMed ID: 24338530
[TBL] [Abstract][Full Text] [Related]
5. Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry.
Da LT; Quan JM; Wu YD
Proteins; 2011 Jun; 79(6):1810-9. PubMed ID: 21465559
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.
Wang T; Kadow JF; Zhang Z; Yin Z; Gao Q; Wu D; Parker DD; Yang Z; Zadjura L; Robinson BA; Gong YF; Spicer TP; Blair WS; Shi PY; Yamanaka G; Lin PF; Meanwell NA
Bioorg Med Chem Lett; 2009 Sep; 19(17):5140-5. PubMed ID: 19664921
[TBL] [Abstract][Full Text] [Related]
7. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
8. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
9. A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity.
Manetti F; Tintori C; Armand-Ugón M; Clotet-Codina I; Massa S; Ragno R; Esté JA; Botta M
J Chem Inf Model; 2006; 46(3):1344-51. PubMed ID: 16711753
[TBL] [Abstract][Full Text] [Related]
10. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.
Lu RJ; Tucker JA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Pickens J; Tandel S; Brahmachary E; Yang Y; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Khasanov A; Ma YA; Jeffries C; Liu C; Proskurina T; Zhu T; Chucholowski A; Li R; Sexton C
J Med Chem; 2007 Dec; 50(26):6535-44. PubMed ID: 18052117
[TBL] [Abstract][Full Text] [Related]
12. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
13. Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.
Vangala R; Sivan SK; Peddi SR; Manga V
J Comput Aided Mol Des; 2020 Jan; 34(1):39-54. PubMed ID: 31792886
[TBL] [Abstract][Full Text] [Related]
14. Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.
Madani N; Perdigoto AL; Srinivasan K; Cox JM; Chruma JJ; LaLonde J; Head M; Smith AB; Sodroski JG
J Virol; 2004 Apr; 78(7):3742-52. PubMed ID: 15016894
[TBL] [Abstract][Full Text] [Related]
15. Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806.
Liu T; Huang B; Zhan P; De Clercq E; Liu X
Eur J Med Chem; 2014 Oct; 86():481-90. PubMed ID: 25203778
[TBL] [Abstract][Full Text] [Related]
16. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.
Langley DR; Kimura SR; Sivaprakasam P; Zhou N; Dicker I; McAuliffe B; Wang T; Kadow JF; Meanwell NA; Krystal M
Proteins; 2015 Feb; 83(2):331-50. PubMed ID: 25401969
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
[TBL] [Abstract][Full Text] [Related]
18. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
[TBL] [Abstract][Full Text] [Related]
19. Does Antibody Stabilize the Ligand Binding in GP120 of HIV-1 Envelope Protein? Evidence from MD Simulation.
Yadav S; Pandey V; Kumar Tiwari R; Ojha RP; Dubey KD
Molecules; 2021 Jan; 26(1):. PubMed ID: 33466381
[TBL] [Abstract][Full Text] [Related]
20. Heterobiaryl human immunodeficiency virus entry inhibitors.
Lu RJ; Tucker JA; Pickens J; Ma YA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Brahmachary E; Khasanov A; Mikel C; Yang Y; Liu C; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Baker B; Sailstad J; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Jeffries C; Chucholowski A; Sexton C
J Med Chem; 2009 Jul; 52(14):4481-7. PubMed ID: 19534463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
